132 related articles for article (PubMed ID: 4888382)
1. G 30 320 or B 663--lampren (Geigy).
Waters MF
Lepr Rev; 1969 Jan; 40(1):21-47. PubMed ID: 4888382
[No Abstract] [Full Text] [Related]
2. Treatment of leprosy with Lampren (B.663 Geigy).
De las Aguas JT
Int J Lepr Other Mycobact Dis; 1971; 39(2):493-503. PubMed ID: 4948089
[No Abstract] [Full Text] [Related]
3. Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)).
Schulz EJ
Lepr Rev; 1971 Sep; 42(3):178-87. PubMed ID: 5151819
[No Abstract] [Full Text] [Related]
4. Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663).
Pettit JH; Rees RJ
Int J Lepr Other Mycobact Dis; 1966; 34(4):391-7. PubMed ID: 6006070
[No Abstract] [Full Text] [Related]
5. B 663 (Lampren) in mycobacterial infections.
Pettit JH
Br J Dermatol; 1969 Oct; 81(10):794-5. PubMed ID: 5379868
[No Abstract] [Full Text] [Related]
6. [. 663 (G 30320 "Geigy"), a new chemotherapeutic agent against leprosy].
Vischer WA
Schweiz Med Wochenschr; 1967 Mar; 97(10):308. PubMed ID: 5585384
[No Abstract] [Full Text] [Related]
7. B.663 (Geigy 30. 320) in the treatment of leprosy. A preliminary report.
Devadason C
Acta Trop; 1969; 26(3):265-9. PubMed ID: 4391239
[No Abstract] [Full Text] [Related]
8. The evaluation of present antileprosy compounds.
Browne SG
Adv Pharmacol (1962); 1969; 7():211-51. PubMed ID: 4190238
[No Abstract] [Full Text] [Related]
9. The treatment of erythema nodosum leprosum with B.663. A controlled study.
Pettit JH
Int J Lepr Other Mycobact Dis; 1967; 35(1):11-6. PubMed ID: 4290017
[No Abstract] [Full Text] [Related]
10. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
Pettit JH; Rees RJ; Ridley DS
Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
[No Abstract] [Full Text] [Related]
11. [Lampren in the treatment of leprosy].
Ahrens T
Schweiz Rundsch Med Prax; 1970 Mar; 59(11):387-9. PubMed ID: 5519711
[No Abstract] [Full Text] [Related]
12. Correlation of laboratory and clinical data during treatment of leprosy.
Pattyn SR; Rollier R; Rollier MR; De Muynck A; Janssens PG; Verdoolaeghe-Van Loo G
Ann Soc Belg Med Trop; 1972; 52(6):537-48. PubMed ID: 4574223
[No Abstract] [Full Text] [Related]
13. Comments on the chemotherapy of leprosy as influenced by present knowledge of Mycobacterium leprae.
Pattyn SR
Lepr Rev; 1973 Sep; 43(3):126-36. PubMed ID: 4120832
[No Abstract] [Full Text] [Related]
14. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
Waters MF; Rees RJ; Sutherland I
Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
[No Abstract] [Full Text] [Related]
15. Antileprosy drugs.
Br Med J; 1971 Jul; 3(5767):174-6. PubMed ID: 4104273
[No Abstract] [Full Text] [Related]
16. B.663 and erythema nodosum leprosum.
Pettit JH
Int J Lepr Other Mycobact Dis; 1967; 35(3):401-2. PubMed ID: 5630363
[No Abstract] [Full Text] [Related]
17. Evaluation of B.663 in human leprosy.
Atkinson AJ; Sheagren JN; Rubio JB; Knight V
Int J Lepr Other Mycobact Dis; 1967; 35(2):119-27. PubMed ID: 5338956
[No Abstract] [Full Text] [Related]
18. Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy.
Hastings RC; Trautman JR; Mansfield RE
Dermatol Int; 1969; 8(1):21-7. PubMed ID: 5343403
[No Abstract] [Full Text] [Related]
19. Erythema nodosum leprosum.
Fowler PD
Int J Lepr Other Mycobact Dis; 1967; 35(3):397-8. PubMed ID: 4318423
[No Abstract] [Full Text] [Related]
20. Management of steroid-dependency with clofazimine (Lamprene or B 663 (Geigy)).
Morgan J
Lepr Rev; 1970 Oct; 41(4):229-32. PubMed ID: 5515679
[No Abstract] [Full Text] [Related]
[Next] [New Search]